Similar results were also achieved when curcumin was used to treat FOLFOX-surviving colon cancer cells, highlighting the importance of EGFR/IGF-1R/Akt signaling inhibition by curcumin in chemo-resistant cells (Patel et al., 2010). This evidence concerns the gene IGF1R and malignant colon neoplasm.